Amala Cancer Research Center, Trichur 680555, Kerala, India.
Pharm Biol. 2010 Mar;48(3):290-5. doi: 10.3109/13880200903116048.
Administration of commonly used anticancer drug cisplatin [cis-diamminedichloroplatinum (II)] at pharmacologically relevant concentrations (12 mg/kg body weight) resulted in severe renal toxicity as evidenced from histopathological observations and biochemical alterations in the renal tissue. The extracts of medicinal plants Hemidesmus indicus L. (Apocynaceae) and Acorus calamus L. (Araceae) protected the renal tissue effectively from cisplatin-induced toxicity. Treatment of cisplatin-administered animals with the plant extracts could prevent the drug-induced oxidative damage in the renal tissue as evidenced from the decreased levels of lipid peroxidation and enhanced activities of the antioxidants in the renal tissue. Cisplatin treatment increased serum urea level to 41.3 +/- 2.86 mg/dL and administration of the extracts of H. indicus and A. calamus brought down the level to 34.54 +/- 0.37 and 30.12 +/- 0.95 mg/dL, respectively. Serum creatinine levels were increased to 1.1 +/- 0.02 mg/dL following cisplatin administration, and treatment with extracts of H. indicus and A. calamus brought this down to 0.76 +/- 0.09 and 0.61 +/- 0.06 mg/dL, respectively. The histopathological observations indicated that treatment with the H. indicus and A. calamus extracts restored the cisplatin-induced structural alterations in the renal tissue.
在药理学相关浓度(12 毫克/千克体重)下给予常用抗癌药物顺铂[顺式-二氨二氯铂(II)]会导致严重的肾毒性,这可以从组织病理学观察和肾组织的生化改变中得到证明。药用植物印度青黛(夹竹桃科)和菖蒲(天南星科)的提取物能有效地保护肾组织免受顺铂引起的毒性。用植物提取物治疗顺铂给药的动物可以防止药物引起的肾组织氧化损伤,这可以从肾组织中脂质过氧化水平降低和抗氧化剂活性增强得到证明。顺铂治疗使血清尿素水平升高至 41.3 +/- 2.86 mg/dL,而给予印度青黛和菖蒲提取物可将水平分别降低至 34.54 +/- 0.37 和 30.12 +/- 0.95 mg/dL。顺铂给药后血清肌酐水平升高至 1.1 +/- 0.02 mg/dL,而给予印度青黛和菖蒲提取物可将其降低至 0.76 +/- 0.09 和 0.61 +/- 0.06 mg/dL。组织病理学观察表明,用印度青黛和菖蒲提取物治疗可恢复顺铂引起的肾组织结构改变。